Nobuhiro Yamaguchi
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nobuhiro Yamaguchi.
Circulation | 2007
Yasuhide Asaumi; Yutaka Kagaya; Morihiko Takeda; Nobuhiro Yamaguchi; Hiroko Tada; Kenta Ito; Jun Ohta; Takashi Shiroto; Kunio Shirato; Naoko Minegishi; Hiroaki Shimokawa
Background— Erythropoietin (Epo) receptors (EpoRs) are expressed in the heart. We have recently demonstrated that the endogenous Epo-EpoR system plays an important protective role in myocardial ischemia in mice and humans. In the present study, we tested our hypothesis that the endogenous Epo-EpoR system in nonhematopoietic cells also plays a protective role against pressure overload-induced cardiac dysfunction in vivo. Methods and Results— Transgene-rescued EpoR-null mutant mice (EpoR−/−rescued) that express EpoR exclusively in the hematopoietic cells were subjected to transverse aortic constriction (TAC). At 1 week after TAC, left ventricular weight and lung weight were significantly increased in EpoR−/−rescued mice compared with wild-type mice, although the fibrotic area was comparably increased after TAC in the 2 genotypes. In the EpoR−/−rescued mice with TAC, left ventricular end-diastolic diameter was significantly increased, left ventricular fractional shortening was significantly decreased, and survival rate was significantly decreased compared with wild-type mice with TAC. Phosphorylation of STAT3 at 5 hours and 1 week after TAC and that of p38 at 5 hours after TAC were significantly increased in wild-type mice but not in EpoR−/−rescued mice. Vascular endothelial growth factor protein expression and capillary density in left ventricular myocardium were significantly decreased in EpoR−/−rescued mice with TAC compared with wild-type mice with TAC. Conclusions— These results suggest that the endogenous Epo-EpoR system in the nonhematopoietic cells plays an important protective role against pressure overload-induced cardiac dysfunction in vivo.
Journal of Molecular and Cellular Cardiology | 2006
Katsuaki Takahashi; Tatsuya Komaru; Satoru Takeda; Morihiko Takeda; Ryoji Koshida; Masaharu Nakayama; Yasunori Kokusho; Yuki Kawakami; Nobuhiro Yamaguchi; Teruo Miyazawa; Hiroaki Shimokawa; Kunio Shirato
Blood | 2007
Shinichiro Koga; Nobuhiro Yamaguchi; Tomoko Abe; Masayoshi Minegishi; Shigeru Tsuchiya; Masayuki Yamamoto; Naoko Minegishi
Nihon Naika Gakkai Zasshi | 2012
Tetsuya Chiba; Takeshi Ishizuka; Tsuyoshi Ogata; Soichiro Tadaki; Hiroshi Fujita; Nobuhiro Yamaguchi; Noriko Onoue; Mitsuaki Tanaka; Tsuyoshi Shinozaki; Yoshihiro Kikuchi
Tohoku Journal of Experimental Medicine | 2008
Nobuhiro Yamaguchi; Koji Kumagai; Koji Fukuda; Yuji Wakayama; Yoshinao Sugai; Masanori Hirose; Hiroaki Shimokawa
Journal of Cardiac Failure | 2017
Hideka Hayashi; Yoshimi Takahashi; Shinsuke Yamanaka; Nobuhiro Yamaguchi; Noriko Onoue; Takeshi Ishizuka; Tsuyoshi Shinozaki
Journal of Cardiac Failure | 2014
Ryosuke Tashiro; Noriko Onoue; Hiroya Rikimaru; Kenichi Tsukita; Taijyu Sato; Hiroshi Fujita; Nobuhiro Yamaguchi; Takeshi Ishizuka; Yasushi Suzuki; Tsuyoshi Shinozaki
Journal of Cardiac Failure | 2013
Taiju Sato; Hiroshi Fujita; Nobuhiro Yamaguchi; Noriko Onoue; Takeshi Ishizuka; Tsuyoshi Shinozaki
Journal of Cardiac Failure | 2012
Tsuyoshi Ogata; Hiroshi Fujita; Nobuhiro Yamaguchi; Noriko Onoue; Mitsuaki Tanaka; Takeshi Ishiduka; Tsuyoshi Shinozaki
Journal of Cardiac Failure | 2012
Yu Katata; Tsuyoshi Ogata; Hiroshi Fujita; Nobuhiro Yamaguchi; Noriko Onoue; Mitsuaki Tanaka; Takeshi Ishizuka; Tsuyoshi Shinozaki